JAN 28, 2021 7:29 AM PST

Researchers Uncover Synapse Mechanism Behind Addiction

WRITTEN BY: Annie Lennon

Researchers have shown that enzymes working at the synapses of medium spiny neurons (MSN) are associated with drug-seeking and extinction behaviors. These novel molecules, they say, may become potential targets for future treatments for drug addiction. 

Researchers have previously found that plasticity at MSNs expressing the D1-type dopamine receptor in the nucleus accumbens part of the brain is associated with drug-seeking behavior. Meanwhile, activity at the D2-type dopamine receptors in the same brain region is linked to extinction behaviors. As such, the present study set out to find why this is the case. 

For the study, the researchers trained rats to self-administer heroin by pushing a lever for ten days, followed by a ten-day withdrawal period. Afterward, they examined the rats’ brains under a microscope to identify enzymatic activity around their MSN synapses. 

In particular, they focused on the activity of extracellular enzymes known as metalloproteinases (MMP). By breaking down proteins that constitute the extracellular matrix around nerve cells, they support synaptic connections. They also, however, make it harder for neurons to remodel synaptic connections from new experiences, which consequently impacts neuroplasticity. 

All in all, the researchers found that drug cues increased MMP activity near D1-type MSNs in the nucleus accumbens and promoted plasticity in cells linked to addiction. Extinction training was, however, found to increase MMP activity around D2 receptor-containing MSNs (cells related to protection against addiction), as opposed to reducing MMP activity around D1 MSNs. 

“This finding suggests that recovery from addiction is not simply a reversal of addiction-related changes in the brain, but rather it also involves the laying down of new anti-addiction changes that protect against substance use.” says Dr. John Krystal, MD, Editor of Biological Psychiatry. 

 

Sources: Neuroscience NewsBiological Psychiatry

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
MAR 04, 2021
Drug Discovery & Development
How Placebo Drugs for Pain Work in the Brain
MAR 04, 2021
How Placebo Drugs for Pain Work in the Brain
Researchers from Dartmouth College have found that pain relief drugs that work via the placebo effect reduce pain-relate ...
MAR 18, 2021
Cannabis Sciences
Migraine Sufferers Who Use Cannabis Have More Headaches
MAR 18, 2021
Migraine Sufferers Who Use Cannabis Have More Headaches
Researchers from Stanford University School of Medicine have found that people who use cannabis for pain relief from chr ...
MAR 24, 2021
Cardiology
Supplement Can Prevent Strokes in Patients with Rare Disease
MAR 24, 2021
Supplement Can Prevent Strokes in Patients with Rare Disease
Scientists have found that it may be possible for people with a rare genetic disorder to prevent fatal strokes by taking ...
MAR 30, 2021
Neuroscience
Prolonged Amygdala Activity Predicts Personal Wellbeing
MAR 30, 2021
Prolonged Amygdala Activity Predicts Personal Wellbeing
Researchers have found that activity in the amygdala (the emotional center of the brain) following exposure to negative ...
APR 10, 2021
Drug Discovery & Development
How New ADHD Drug for Children Differs from Adderall
APR 10, 2021
How New ADHD Drug for Children Differs from Adderall
Over 1 in 10 children in the US aged between 5 and 17 have been diagnosed with attention deficit hyperactivity ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
Loading Comments...